Zobrazeno 1 - 10
of 27 706
pro vyhledávání: '"Urothelial carcinoma"'
Autor:
Ayatsugu Otsuka, Norifumi Sawada, Ryosuke Suda, Fumiakira Yano, Takuya Osada, Yuko Otake, Hiroshi Shimura, Takanori Mochizuki, Daiki Harada, Junko Goto, Tomomi Watanabe, Tadatsugu Hosokawa, Satoru Kira, Kyoichiro Tsuchiya, Takeshi Moriguchi, Takahiko Mitsui
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 891-899 (2024)
Introduction: Enfortumab vedotin (EV) is an antibody-drug conjugate combining a monoclonal antibody targeting nectin-4 with a highly potent microtubule disrupting agent. EV is expected to be a candidate for the third-line treatment for urothelial car
Externí odkaz:
https://doaj.org/article/ebb1eb10be42431c90586f9e3184c4b1
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Urinary bladder cancer, is the 10th most common global cancer, diagnosed in over 600,000 people causing 200,000 deaths annually. Artemisinin and its derivatives are safe compounds that have recently been proven to possess potent a
Externí odkaz:
https://doaj.org/article/bcaa36ca5ad241e8adea5a6f82983709
Autor:
Tsu-Chen Lin, Guan-Heng Chen, Chin-Chung Yeh, Hung-Lung Ke, Wei-Ming Li, Yao-Chou Tsai, Shu-Yu Wu, Chao-Yuan Huang, Chung-Hsin Chen, Wun-Rong Lin, Marcelo Chen, Shih-Hsiu Lo, See-Tong Pang, Po-Hung Lin
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Patients with end stage renal disease (ESRD) are at high risk of developing upper tract urothelial carcinoma (UTUC). Due to high recurrence rate of UTUC in contralateral kidney and ureter, and high risk of complications related to surgery an
Externí odkaz:
https://doaj.org/article/e06680c793284531a64ebdeb3c0a2151
Autor:
Jiayi Zhuo, Jingjing Han, Lingjie Yang, Yu Wang, Guangzi Shi, Zhuoheng Yan, Lu Yang, Riyu Han, Fengqiong Huang, Xiaohua Ban, Xiaohui Duan
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Sarcomatoid urothelial carcinoma (SUC) is a rare and highly malignant form of bladder cancer with a poor prognosis. Currently, there is limited information on the imaging features of bladder SUC and reliable indicators for disting
Externí odkaz:
https://doaj.org/article/c19a343bfeb74565a7be9728f6634eb7
Autor:
Masato Yanagi, Tomonari Kiriyama, Jun Akatsuka, Yuki Endo, Hayato Takeda, Tsutomu Hamasaki, Taiji Nishimura, Yukihiro Kondo
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Prolonged laparoscopic nephroureterectomy (LNU) for upper tract urothelial cancer (UTUC) can increase the frequency of intravesical recurrence after surgery. Therefore, it is important for urological surgeons to have knowledge on
Externí odkaz:
https://doaj.org/article/d5d879013d6d41868e2ef297684bf46b
Autor:
K.C. Sharan, Manish Rohilla, Pranab Dey, Radhika Srinivasan, Nandita Kakkar, Ravimohan S. Mavuduru
Publikováno v:
Journal of Cytology, Vol 41, Iss 3, Pp 137-142 (2024)
Introduction: Urinary cytology (UrCy) is highly sensitive to diagnosing high-grade urothelial carcinoma (HGUC) but cannot predict muscularis propria invasion. Further, the atypical urothelial cell category (AUC) may have variable outcomes. Image morp
Externí odkaz:
https://doaj.org/article/4c8ac6a38f774f4691db030f9af0dba1
Autor:
Irfan Cicin, Elizabeth R. Plimack, Howard Gurney, Raya Leibowitz, Boris Y. Alekseev, Francis X. Parnis, Avivit Peer, Andrea Necchi, Joaquim Bellmunt, Hiroyuki Nishiyama, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Thomas Powles, Cora N. Sternberg
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Indoleamine 2,3-dioxygenase 1 (IDO1) levels correlate with poor outcomes in urothelial carcinoma (UC). IDO1 and programmed death-ligand 1 (PD-L1) are often co-expressed. Epacadostat is a potent and highly selective inhibitor of ID
Externí odkaz:
https://doaj.org/article/263d9199baf8485699909ce6591e41d9
Autor:
Andrea Necchi, Michiel S. Van der Heijden, Dmytro Trukhin, Avivit Peer, Howard Gurney, Boris Y. Alekseev, Francis X. Parnis, Raya Leibowitz, Maria De Santis, Petros Grivas, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Arjun V. Balar, Ronald de Wit
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Indoleamine 2,3- dioxygenase 1 (IDO1) is an immunosuppressive enzyme that has been correlated with shorter disease-specific survival in patients with urothelial carcinoma (UC). IDO1 may counteract the antitumor effects of immune c
Externí odkaz:
https://doaj.org/article/37a2f0fcea5140a684940d22b18e5a1a
Publikováno v:
BMC Surgery, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background SII, PNI, SIRI, AAPR, and LIPI are prognostic scores based on inflammation, nutrition, and immunity. The purpose of this study was to examine the prognostic value of the SII, PNI, SIRI, AAPR, and LIPI in patients with UTUC who und
Externí odkaz:
https://doaj.org/article/4236372fa5534d8f967e0dfe2a7c70aa
Autor:
Cen Wu, Xiaoyu Wei, Zhiyang Huang, Zhixiong Zheng, Wei Zhang, Jiajun Chen, Hongchang Hong, Weili Li
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background Bladder cancer is a common malignancy with high recurrence rate. Early diagnosis and recurrence surveillance are pivotal to patients’ outcomes, which require novel minimal-invasive diagnostic tools. The urinary microbiome is ass
Externí odkaz:
https://doaj.org/article/4560bba1c92f43a2b2f601a8626b329e